SRCL
Get informed when a big investor buys or sells
+ FollowOvervalued by 80.3% based on the discounted cash flow analysis.
| Market cap | $5.75 Billion |
|---|---|
| Enterprise Value | $7.72 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.23 |
| Beta | 1.11 |
| Outstanding Shares | 92,700,000 |
| P/E Ratio | -267.61 |
|---|---|
| PEG | 33.88 |
| Price to Sales | 2.21 |
| Price to Book Ratio | 2.3 |
| Enterprise Value to Revenue | 2.94 |
| Enterprise Value to EBIT | 47.1 |
| Enterprise Value to Net Income | 382 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.78 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
This committee directly regulates the FDA (influencing pharmaceutical waste disposal) and labor laws (impacting Stericycle's operational costs and employment practices), and significantly influences the healthcare sector, a primary client base.
This committee directly regulates the EPA, which is a primary regulatory body for Stericycle's hazardous and medical waste operations, air emissions, and water discharge permits, critically impacting its costs and business model.